SOX7 and ovarian cancer: Our results demonstrated that the expression levels of SOX7 and its targets, COX-2 and cyclin D1, have an inverse relationship, further supporting our hypothesis that SOX7 is a negative regulator in the Wnt/β-catenin signaling pathway in ovarian cancer.